CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 16 of the 23 sources its claims cite were checked for support.

Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda

Open access

Abstract

BACKGROUND: In low-resource settings, limited laboratory capacity adds to the burden of central nervous system (CNS) infections in children and spurs overuse of antibiotics. The commercially available BioFire® FilmArray® Meningitis/Encephalitis Panel (FA-ME) with its capability to simultaneously detect 14 pathogens in cerebrospinal fluid (CSF), could potentially narrow such a diagnostic gap. METHODS: In Mbarara, Uganda, we compared clinical utility (clinical turnaround time [cTAT], microbial yield, and influence on patient outcome and antibiotic exposure) of FA-ME with bacterial culture, in children 0-12 years with suspected CNS infection. RESULTS: Of 212 enrolled children, CSF was sampled from 194. All samples underwent bacterial culture, of which 193 also underwent FA-ME analyses. FA-ME analyses prospectively influenced care for 169 of the 193 patients, and they constituted an 'Index group'. The remaining 43/212 patients constituted a 'Reference group'. Of all 194 CSF-sampled patients, 87% (168) had received antibiotics before lumbar puncture. Median cTAT for FA-ME was 4.2 h, vs. two days for culture. Bacterial yield was 12% (24/193) and 1.5% (3/194) for FA-ME and culture, respectively. FA-ME viral yield was 12% (23/193). Fatality rate was 14% in the Index group vs. 19% in the Reference group (P = 0.20). From clinician receival of FA-ME results, median antibiotic exposure was 6 days for bacteria-negative vs. 13 days for bacteria-positive patients (P = 0.03). Median hospitalization duration was 7 vs. 12 days for FA-ME negative and positive patients, respectively (P < 0.01). CONCLUSIONS: In this setting, clinical FA-ME utility was found in a higher and faster microbial yield and shortened hospitalization and antibiotic exposure of patients without CSF pathology. More epidemiologically customized pathogen panels may increase FA-ME utility locally, although its use in similar settings would require major cost reductions. TRIAL REGISTRATION: The trial was registered with clinicaltrials.gov (NCT03900091) in March 2019, and its protocol was published in November 2020.

Overview

CoChat Summary

## TL;DR

This prospective study in southwestern Uganda found that the FilmArray® meningitis/encephalitis panel (FA-ME) gave faster and higher-yield CSF microbiology than culture in children with suspected CNS infection. It also shortened antibiotic exposure and hospitalization among FA-ME-negative patients, but the authors emphasize that high cost and local epidemiology limit routine use.

## Key findings

  • Among 212 enrolled children, CSF was sampled from 194; FA-ME was performed on 193 samples and culture on all 194 CSF samples.
  • FA-ME microbial yield exceeded culture: bacteria were detected in 24/193 (12%) by FA-ME versus 3/194 (1.5%) by culture; FA-ME also detected viruses in 23/193 (12%) samples.
  • Median clinical turnaround time was 4.2 hours for FA-ME versus 2 days for culture.
  • After clinicians received FA-ME results, median antibiotic exposure was 6 days for bacteria-negative patients versus 13 days for bacteria-positive patients (P = 0.03), and median hospitalization was 7 versus 12 days for FA-ME-negative versus FA-ME-positive patients (P < 0.01).
  • Fatality was 14% in the Index group versus 19% in the Reference group (P = 0.20), and overall mortality did not differ significantly by whether diagnosis was supported by FA-ME.

## Methods

  • Prospective observational study nested in the PI-POC trial, conducted March 2019 to July 2020 at two hospitals in Mbarara, southwestern Uganda, among children aged 0–12 years hospitalized with suspected CNS infection.
  • Compared FA-ME with bacterial culture for clinical utility outcomes: clinical turnaround time (defined as lumbar puncture to clinicians receiving results), microbial yield, patient outcome, antibiotic exposure, and hospitalization duration.
  • Used descriptive statistics plus Mann-Whitney U tests for continuous variables and chi-square tests for categorical variables.

## Limitations

  • The study states it did not routinely perform confirmatory testing with alternative molecular methods (e.g., GeneXpert, CrAg), so diagnostic accuracy could not be assessed.
  • The study lacked a formal control group without FA-ME, which the authors say was considered unethical because empiric antibiotics before lumbar puncture already reduced culture yield.
  • The unplanned Reference group was not matched to the Index group; seven Reference participants had severe clinical conditions, which the authors say could have introduced selection bias.
  • Evidence made evident by the text: many children had antibiotics before lumbar puncture (168/194, 87%), which likely lowered culture yield and complicates comparison with FA-ME.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12879-025-10732-w

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Microorganisms detectable by the FilmArray ME panel [18]
Fig. 1 Microorganisms detectable by the FilmArray ME panel [18]CC BY · PubMed Central
Fig. 2 A and B. Schematic illustration of clinical turnaround time (cTAT); and cTAT illustrated as part of the total patient management time. cTAT = Clinical turnaround time. LP = Lumbar puncture. TAT = Turnaround time. CSF = Cerebrospinal fluid. FA-ME = FilmArray ME Panel
Fig. 2 A and B. Schematic illustration of clinical turnaround time (cTAT); and cTAT illustrated as part of the total patient management time. cTAT = Clinical turnaround time. LP = Lumbar puncture. TAT = Turnaround time. CSF = Cerebrospinal fluid. FA-ME = FilmArray ME PanelCC BY · PubMed Central
Fig. 3 Flowchart of study participants. CSF = cerebrospinal fluid. FA-ME = FilmArray ME Panel. LP = Lumbar puncture
Fig. 3 Flowchart of study participants. CSF = cerebrospinal fluid. FA-ME = FilmArray ME Panel. LP = Lumbar punctureCC BY · PubMed Central
Fig. 4 Clinical turnaround time (cTAT) of FA-ME analyses (hours), broken down between hospitals. MRRH = Mbarara Regional Referral Hospital. HICH = Holy Innocents Children’s Hospital
Fig. 4 Clinical turnaround time (cTAT) of FA-ME analyses (hours), broken down between hospitals. MRRH = Mbarara Regional Referral Hospital. HICH = Holy Innocents Children’s HospitalCC BY · PubMed Central
Fig. 5 Breakdown of duration of each step (hours) of the clinical turnaround time (cTAT) of the FilmArray ME panel, presented with median and IQR. LP = Lumbar puncture. FA-ME = FilmArray ME Panel
Fig. 5 Breakdown of duration of each step (hours) of the clinical turnaround time (cTAT) of the FilmArray ME panel, presented with median and IQR. LP = Lumbar puncture. FA-ME = FilmArray ME PanelCC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 1 Not checked · 34 Own results and interpretations

23 more claims

Create a free account to see all 43 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. Institute for Health Metrics and Evaluation: Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) reference life table. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME); 2021. [Available from: ghdx.healthdata.org/.
  2. First of 3 diagnostic tests for SARS-CoV-. 2 coronavirus available from bioMérieux [press release]. https://www.biomerieux.com/en/novel-coronavirus-covid-19, 11 March.

Cited by

See all 8

Metadata

Authors
Rasti, R., Kumbakumba, E., Nanjebe, D., Mlotshwa, P., Nassejje, M., Mzee, J., Businge, S., Akankwasa, G., Nyehangane, D., Gantelius, J., Boum, Y., Mårtensson, A., Mwanga-Amumpaire, J., Alfvén, T., & Gaudenzi, G.
Affiliations
  • Karolinska Institutet (SE)
  • Mbarara University of Science and Technology (UG)
  • Epicentre Uganda (UG)
  • Holy Innocents Children's Hospital (UG)
  • Science for Life Laboratory (SE)
  • Uppsala University (SE)
Corresponding author
Rasti, Reza
Venue
BMC Infectious Diseases
Published
2025-03-22
Volume
25
Issue
1
Pages
396-396
ISSN
1471-2334 (ISSN-L)
OpenAlex
W4408729760
Cited by
8
References
35
Citations by year
2026: 5 · 2025: 3
FWCI
4.35
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Karolinska Institute
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords
FilmArray Meningitis/Encephalitis panel, central nervous system infection, pediatric meningitis, encephalitis, cerebrospinal fluid, molecular diagnosis, bacterial culture comparison, antibiotic exposure, resource-limited settings, southwestern Uganda, length of hospital stay, fatality rate, virus detection, antimicrobial stewardship, point-of-care testing
MeSH terms
Anti-Bacterial Agents, Bacteria, Central Nervous System Infections, Child, Child, Preschool, Encephalitis, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Prospective Studies, Uganda, Molecular Diagnostic Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda. https://app.cochat.ai/papers/10.1186/s12879-025-10732-w
The paper
Rasti, R., Kumbakumba, E., Nanjebe, D., Mlotshwa, P., Nassejje, M., Mzee, J., Businge, S., Akankwasa, G., Nyehangane, D., Gantelius, J., Boum, Y., Mårtensson, A., Mwanga-Amumpaire, J., Alfvén, T., & Gaudenzi, G. (2025). Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-10732-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.